The Network for Excellence in Health Innovation finds potential areas of innovation and then tries to eliminate the obstacles to those ideas so its members can achieve the triple aim, according to Susan Dentzer, president and CEO of The Network for Excellence in Health Innovation.
The Network for Excellence in Health Innovation finds potential areas of innovation and then tries to eliminate the obstacles to those ideas so its members can achieve the triple aim, according to Susan Dentzer, president and CEO.
Transcript (slightly modified)
What are your key goals as the new president and CEO of the Network for Excellence in Health Innovation?
So, at NEHI, Network for Excellence in Health Innovation, we really do take seriously this notion of innovation. We’re a policy institute, a think tank, sitting within a membership organization, and we look for ways to engage our broad membership — payers, providers, patient groups, biopharmaceutical companies, and others – in innovating, looking for areas where we could innovate around the triple aim, and then in particular, solving problems that get in the way of that innovation.
Taking the obstacles out, or at least beginning to understand what are the obstacles that stand in the way of innovation, whether they are inherent to systems or organizations or whether they’re related to policies at the federal, state, or local level. And then, identify what needs to happen to remove those obstacles and actually allow the innovations that have this amazing potential to improve health or improve care or create more sustainable costs, allow those to flourish.
So we are already engaged in activities that further those goals and we’ll be doing more and more of those in the future. Looking for ways where we can solve problems in healthcare by bringing the sectors together and brainstorming how we can achieve those results.
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD
January 28th 2025The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes (T2D) and chronic kidney disease (CKD), addressing their cardiovascular (CV) and kidney disease risks.
Read More